1. Home
  2. BLZE vs IMRX Comparison

BLZE vs IMRX Comparison

Compare BLZE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$4.99

Market Cap

273.4M

Sector

Technology

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$6.40

Market Cap

232.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
IMRX
Founded
2007
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.4M
232.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BLZE
IMRX
Price
$4.99
$6.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$9.50
$17.20
AVG Volume (30 Days)
884.2K
1.1M
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$141,859,000.00
N/A
Revenue This Year
$16.43
N/A
Revenue Next Year
$11.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.73
N/A
52 Week Low
$3.94
$1.10
52 Week High
$10.86
$10.08

Technical Indicators

Market Signals
Indicator
BLZE
IMRX
Relative Strength Index (RSI) 33.89 43.00
Support Level $4.50 $6.42
Resistance Level $4.78 $6.81
Average True Range (ATR) 0.26 0.47
MACD 0.18 -0.10
Stochastic Oscillator 97.65 9.07

Price Performance

Historical Comparison
BLZE
IMRX

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: